Evidence for colorectal cancer screening

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 4, 2010, Pages 417-425

  Bretthauer, Michael ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal cancer screening

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FOLLOW UP; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD TEST; RISK REDUCTION; SIGMOIDOSCOPY;

AGED; CLINICAL TRIALS AS TOPIC; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 77956583115     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.06.005     Document Type: Article

References (44)

1. Globocan database http://www-dep.iarc.fr 2002 [accessed 22.05.10]
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD.
3. J.M.G. Wilson, and Y.G. Jungner Principles and practice of mass screening for disease 1968 WHO Geneva
4. R.F. Redberg, and J. Walsh Pay now, benefits may follow-the case of cardiac computed tomographic angiography N Engl J Med 359 2008 2309 2311
5. M. Bretthauer The capsule and colorectal cancer screening-the crux of the matter N Engl J Med 361 2009 300 301
6. L. von Karsa, A. Anttila, G. Ronco, A. Ponti, N. Malila, and M. Arbyn Cancer screening in the European Union. Report on the implementation of the Council recommendation on cancer screening-First Report 2008 European Commission Luxembourg
7. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irvig Cochran systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update Am J Gastroenterol 103 2008 1541 1549
8. E.P. Whitlock, J.S. Lin, E. Liles, T.L. Beil, and R. Fu Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force Ann Intern Med 149 2008 638 658
9. N. Malila, T. Oivanen, O. Malminiemi, and M. Hakama Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design Br Med J 337 2008 a2261
10. L.G. van Rossum, A.F. van Rijn, R.J. Laheij, M.G. van Oijen, P. Fockens, and H.H. van Krieken Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
11. S. Hundt, U. Haug, and H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 2009 162 169
12. J. Allison Colorectal cancer screening guidelines: the importance of evidence and transparency Gastroenterology 138 2010 1648 1652
13. O. Kronborg, C. Fenger, J. Olsen, O.D. Jørgensen, and O. Søndergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
14. O.D. Jorgensen, O. Kronborg, and C. Fenger A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds Gut 50 2002 29 32
15. O. Kronborg, O.D. Jorgensen, C. Fenger, and M. Rasmussen Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds Scand J Gastroenterol 39 2004 846 851
16. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, and L.M. Schuman Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1993 1365 1371
17. J.S. Mandel, T.R. Church, F. Ederer, and J. Bond Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood J Natl Cancer Inst 91 1999 434 437 (Pubitemid 29128279)
18. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, and S.S. Amar Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
19. M.H. Robinson, J.D. Hardcastle, S.M. Moss, S.S. Amar, J.O. Chamberlain, and N.C.M. Armitage The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer Gut 45 1999 588 592
20. E. Lindholm, H. Brevinge, and E. Haglin Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer Br J Surg 95 2008 1029 1036
21. J.S. Mandel, T.R. Church, J.H. Bond, F. Ederer, M.S. Geisser, and S.J. Mongin The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 30 343 2000 1603 1607
22. S. Zheng, K. Chen, X. Liu, X. Ma, H. Yu, and K. Chen Cluster randomization trial of sequence mass screening for colorectal cancer Dis Colon Rectum 46 2003 51 58
23. J.A. Hanley Analysis of mortality data from cancer screening studies. Looking in the right window Epidemiology 16 2005 786 790
24. U.S. Preventive Services Task Force Screening for Colorectal Cancer U.S. preventive services task force recommendation statement Ann Intern Med 149 2008 627 637
25. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and C. Dash Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595 (Pubitemid 351615355)
26. T.R. Levin, F.A. Farraye, R.E. Schoen, G. Hoff, W. Atkin, and J.H. Bond Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group Gut 54 2005 807 813
27. T.F. Imperiale, D.R. Wagner, C.Y. Lin, G.N. Larkin, J.D. Rogge, and D.F. Ransohoff Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343 2000 169 174
28. W. Atkin, P. Rogers, C. Cardwell, C. Cook, J. Cuzick, and J. Wardle Wide variation in adenoma detection rates at screening flexible sigmoidoscopy Gastroenterology 126 2004 1247 1256
29. M. Bretthauer, E. Skovlund, T. Grotmol, E. Thiis-Evensen, G. Gondal, and G. Huppertz-Hauss Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy for colorectal cancer screening Scand J Gastroenterol 2003 38 2003 635 642
30. M. Fracchia, C. Senore, P. Armaroli, R. Ferraris, R.D. Placido, and A. Musso Assessment of the multiple components of the variability in the adenoma detection rate in sigmoidoscopy screening, and lessons for training Endosocpy 42 2010 448 455
31. E. Thiis-Evensen, G.S. Hoff, J. Sauar, F. Langmark, B.M. Majak, and M.H. Vatn Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I Scand J Gastroenterol 34 1999 414 420
32. W.S. Atkin, R. Edwards, I. Kralj-Hans, K. Wooldrage, A.R. Hart, and J.M. Northover Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 2010 1624 1633
33. G. Hoff, T. Grotmol, E. Skovlund, M. Bretthauer for the Norwegian colorectal cancer prevention group Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised trial Br Med J 338 2009 b1846
34. J. Cuzick, F.H. Cafferty, R. Edwards, H. Møller, and S.W. Duffy Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK flexible sigmoidoscopy screening trial J Med Screen 14 2007 178 185
35. M. Bretthauer Which tool is best for colorectal cancer screening? Flexible sigmoidoscopy shows promise, but randomised data are needed Br Med J 340 2010 c2831
36. J.L. Weissfeld, R.E. Schoen, P.F. Pinsky, R.S. Bresalier, T. Church, and S. Yurgalevitch Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial J Natl Cancer Inst 97 2005 989 997
37. N. Segnan, C. Senore, B. Andreoni, H. Aste, L. Bonelli, and C. Crosta Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoccopy"-SCORE J Natl Cancer Inst 94 2002 1763 1772
38. G. Hoff, M. Vatn, E. Gjone, S. Larsen, and J. Sauar Epidemiology of polyps in the rectum and sigmoid colon. design of a population screening study Scand J Gastroenterol 20 1985 351 355 (Pubitemid 15089054)
39. UK flexible sigmoidoscopy screening trial investigators Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial Lancet 359 2002 1291 1300
40. G. Gondal, T. Grotmol, B. Hofstad, M. Bretthauer, T.J. Eide, and G. Hoff The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years Scand J Gastroenterol 38 2003 635 642
41. G. Hoff, and J.A. Dominitz Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 59 2010 407 414
42. D.F. Ransohoff Have we oversold colonoscopy? Gastroenterology 129 2005 1815
43. Colorectal cancer screening in average-risk population: immunochemical 11 fecal occult blood testing versus colonoscopy ClinicalTrials.gov www.clinicaltrials.gov/ct2/show/NCT00906997
44. Northern-European Initiative on colorectal cancer (NordICC) ClinicalTrials.10gov http://clinicaltrials.gov/ct2/show/NCT00883792